Rani Therapeutics Holdings, Inc. (RANI) Tops Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts RANI Hot Sheet
Join SI Premium – FREE
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q1 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $172 thousand.
For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
